| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.664 | 0.028 | 0.664 | Caspase 9 stimulant | 0.536 0.048 CID_34180809 | ||
| 0.629 | 0.013 | 0.629 | Vasodilator, peripheral | 0.557 0.02 CID_34180809 | ||
| 0.604 | 0.004 | 0.604 | 5 Hydroxytryptamine 1A agonist | 0.2 0.009 CID_34180809 | ||
| 0.59 | 0.004 | 0.59 | 5 Hydroxytryptamine agonist | 0.276 0.009 CID_34180809 | ||
| 0.505 | 0.005 | 0.505 | Calcium channel activator | 0.472 0.008 CID_34180809 | ||
| 0.502 | 0.033 | 0.502 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.391 0.109 CID_34180809 | ||
| 0.491 | 0.028 | 0.492 | GABA C receptor rho-3 antagonist | 0.492 0.028 CID_34180809 | CID_34180809 | |
| 0.463 | 0.011 | 0.463 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.405 0.02 CID_34180809 | ||
| 0.45 | 0.005 | 0.45 | 5 Hydroxytryptamine 1 agonist | 0.14 0.015 CID_34180809 | ||
| 0.47 | 0.032 | 0.47 | 5 Hydroxytryptamine release stimulant | 0.419 0.042 CID_34180809 | ||
| 0.439 | 0.004 | 0.439 | Alpha adrenoreceptor agonist | 0.243 0.006 CID_34180809 | ||
| 0.455 | 0.019 | 0.455 | Hypoxia-inducible factor 1 alpha inhibitor | 0.445 0.021 CID_34180809 | ||
| 0.431 | 0.015 | 0.431 | Interleukin agonist | 0.353 0.028 CID_34180809 | ||
| 0.414 | 0.024 | 0.414 | Superoxide dismutase inhibitor | 0.412 0.025 CID_34180809 | ||
| 0.408 | 0.021 | 0.408 | Potassium channel blocker | |||
| 0.375 | 0.009 | 0.375 | Antiadrenergic | 0.216 0.021 CID_34180809 | ||
| 0.374 | 0.009 | 0.374 | Adrenaline antagonist | 0.214 0.021 CID_34180809 | ||
| 0.359 | 0.004 | 0.359 | Alpha 1 adrenoreceptor agonist | 0.149 0.009 CID_34180809 | ||
| 0.412 | 0.061 | 0.412 | Antiobesity | 0.272 0.138 CID_34180809 | ||
| 0.341 | 0.007 | 0.378 | GABA C receptor agonist | 0.378 0.006 CID_34180809 | CID_34180809 | |
| 0.388 | 0.066 | 0.388 | MAP kinase kinase 6 inhibitor | |||
| 0.36 | 0.051 | 0.36 | Nootropic | |||
| 0.313 | 0.016 | 0.313 | Protein kinase (CK1) inhibitor | 0.18 0.048 CID_34180809 | ||
| 0.333 | 0.037 | 0.333 | Tyrosine kinase inhibitor | |||
| 0.3 | 0.005 | 0.3 | Janus tyrosine kinase 2 inhibitor | 0.069 0.056 CID_34180809 | ||
| 0.327 | 0.036 | 0.327 | Psychostimulant | 0.253 0.058 CID_34180809 | ||
| 0.323 | 0.036 | 0.323 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.26 0.054 CID_34180809 | ||
| 0.298 | 0.013 | 0.298 | Activin receptor-like kinase 2 inhibitor | 0.225 0.027 CID_34180809 | ||
| 0.294 | 0.009 | 0.294 | Alpha 2b adrenoreceptor antagonist | 0.185 0.027 CID_34180809 | ||
| 0.286 | 0.004 | 0.286 | Alpha 2 adrenoreceptor agonist | 0.176 0.005 CID_34180809 | ||
| 0.283 | 0.005 | 0.283 | Activin receptor-like kinase 4 inhibitor | 0.155 0.026 CID_34180809 | ||
| 0.31 | 0.035 | 0.367 | Peroxidase inhibitor | 0.367 0.025 CID_34180809 | CID_34180809 | |
| 0.284 | 0.013 | 0.284 | Protein kinase (CK1) delta inhibitor | 0.179 0.037 CID_34180809 | ||
| 0.306 | 0.039 | 0.306 | Cyclic AMP phosphodiesterase inhibitor | 0.266 0.056 CID_34180809 | ||
| 0.312 | 0.046 | 0.312 | HERG channel blocker | |||
| 0.279 | 0.017 | 0.279 | Alpha adrenoreceptor antagonist | 0.114 0.05 CID_34180809 | ||
| 0.262 | 0.003 | 0.262 | 5 Hydroxytryptamine 3 agonist | 0.167 0.004 CID_34180809 | ||
| 0.265 | 0.006 | 0.265 | CXC chemokine 4 receptor antagonist | 0.096 0.025 CID_34180809 | ||
| 0.263 | 0.005 | 0.263 | Tyk2 inhibitor | 0.105 0.026 CID_34180809 | ||
| 0.292 | 0.04 | 0.292 | Death-associated protein kinase 3 inhibitor | 0.24 0.056 CID_34180809 | ||
| 0.25 | 0.004 | 0.25 | 5 Hydroxytryptamine 2C agonist | 0.15 0.005 CID_34180809 | ||
| 0.256 | 0.011 | 0.256 | Alpha 2 adrenoreceptor antagonist | 0.154 0.026 CID_34180809 | ||
| 0.247 | 0.005 | 0.247 | 5 Hydroxytryptamine 3A agonist | 0.221 0.01 CID_34180809 | ||
| 0.263 | 0.023 | 0.263 | 5 Hydroxytryptamine antagonist | |||
| 0.279 | 0.042 | 0.279 | MAP-kinase-activated kinase 5 inhibitor | 0.227 0.076 CID_34180809 | ||
| 0.239 | 0.01 | 0.239 | Alpha 2a adrenoreceptor antagonist | 0.163 0.02 CID_34180809 | ||
| 0.282 | 0.055 | 0.282 | 5 Hydroxytryptamine uptake stimulant | 0.271 0.063 CID_34180809 | ||
| 0.236 | 0.01 | 0.236 | MAP kinase kinase 5 inhibitor | 0.21 0.023 CID_34180809 | ||
| 0.232 | 0.01 | 0.232 | Polo-like kinase-4 inhibitor | 0.19 0.018 CID_34180809 | ||
| 0.24 | 0.021 | 0.24 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.066 CID_34180809 | ||
| 0.251 | 0.032 | 0.266 | Nitric-oxide synthase stimulant | 0.266 0.023 CID_34180809 | CID_34180809 | |
| 0.235 | 0.016 | 0.235 | Alpha 1 adrenoreceptor antagonist | 0.084 0.051 CID_34180809 | ||
| 0.236 | 0.023 | 0.236 | 5 Hydroxytryptamine 2 antagonist | 0.1 0.071 CID_34180809 | ||
| 0.222 | 0.009 | 0.222 | Janus tyrosine kinase 3 inhibitor | 0.077 0.046 CID_34180809 | ||
| 0.234 | 0.024 | 0.234 | Toll-Like receptor 9 antagonist | 0.15 0.063 CID_34180809 | ||
| 0.221 | 0.014 | 0.221 | Alpha 2c adrenoreceptor antagonist | 0.146 0.034 CID_34180809 | ||
| 0.209 | 0.01 | 0.209 | ALK inhibitor | 0.131 0.025 CID_34180809 | ||
| 0.228 | 0.03 | 0.228 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.101 0.079 CID_34180809 | ||
| 0.251 | 0.053 | 0.251 | MAP kinase kinase 2 inhibitor | 0.222 0.068 CID_34180809 | ||
| 0.21 | 0.014 | 0.21 | Alpha 1b adrenoreceptor antagonist | 0.086 0.042 CID_34180809 | ||
| 0.258 | 0.061 | 0.292 | DNA synthesis inhibitor | 0.292 0.046 CID_34180809 | CID_34180809 | |
| 0.21 | 0.015 | 0.21 | Alpha 1a adrenoreceptor antagonist | 0.074 0.048 CID_34180809 | ||
| 0.238 | 0.044 | 0.238 | Focal adhesion kinase 2 inhibitor | 0.2 0.069 CID_34180809 | ||
| 0.329 | 0.134 | 0.329 | 5 Hydroxytryptamine release inhibitor | 0.311 0.153 CID_34180809 | ||
| 0.208 | 0.014 | 0.208 | 5 Hydroxytryptamine 1A antagonist | 0.064 0.05 CID_34180809 | ||
| 0.209 | 0.016 | 0.209 | 5 Hydroxytryptamine 1 antagonist | 0.066 0.058 CID_34180809 | ||
| 0.256 | 0.064 | 0.256 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.241 | 0.053 | 0.241 | DNA methylase inhibitor | 0.189 0.087 CID_34180809 | ||
| 0.212 | 0.026 | 0.212 | Glycogen synthase kinase-3 beta inhibitor | 0.103 0.074 CID_34180809 | ||
| 0.225 | 0.04 | 0.225 | Tumour necrosis factor antagonist | 0.188 0.061 CID_34180809 | ||
| 0.188 | 0.003 | 0.188 | Vascular adhesion protein 1 inhibitor | 0.09 0.004 CID_34180809 | ||
| 0.198 | 0.014 | 0.201 | Adenylate cyclase stimulant | 0.201 0.013 CID_34180809 | CID_34180809 | |
| 0.238 | 0.056 | 0.238 | Anesthetic general | 0.172 0.093 CID_34180809 | ||
| 0.207 | 0.025 | 0.207 | 5 Hydroxytryptamine 2B antagonist | 0.113 0.068 CID_34180809 | ||
| 0.331 | 0.15 | 0.331 | MAP kinase 1 inhibitor | |||
| 0.186 | 0.005 | 0.186 | Janus tyrosine kinase 1 inhibitor | |||
| 0.19 | 0.01 | 0.19 | Alpha 1d adrenoreceptor antagonist | 0.07 0.035 CID_34180809 | ||
| 0.209 | 0.029 | 0.209 | Hemostatic | 0.183 0.04 CID_34180809 | ||
| 0.188 | 0.009 | 0.188 | Heat shock protein 70 antagonist | 0.169 0.018 CID_34180809 | ||
| 0.216 | 0.037 | 0.216 | Polo-like kinase-3 inhibitor | 0.192 0.05 CID_34180809 | ||
| 0.213 | 0.034 | 0.213 | Cyclin-dependent kinase inhibitor | 0.12 0.074 CID_34180809 | ||
| 0.208 | 0.03 | 0.208 | Glycogen synthase kinase-3 inhibitor | |||
| 0.188 | 0.01 | 0.188 | Protein kinase C delta inhibitor | 0.166 0.015 CID_34180809 | ||
| 0.208 | 0.031 | 0.208 | Cyclin-dependent kinase 7 inhibitor | 0.144 0.064 CID_34180809 | ||
| 0.226 | 0.051 | 0.226 | I kappa B kinase epsilon inhibitor | 0.206 0.066 CID_34180809 | ||
| 0.229 | 0.055 | 0.608 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.608 0.005 CID_34180809 | CID_34180809 | |
| 0.19 | 0.021 | 0.19 | 5 Hydroxytryptamine 2A antagonist | 0.077 0.061 CID_34180809 | ||
| 0.171 | 0.005 | 0.171 | Caspase 7 inhibitor | 0.161 0.005 CID_34180809 | ||
| 0.196 | 0.031 | 0.196 | GABA C receptor rho-2 antagonist | 0.183 0.04 CID_34180809 | ||
| 0.168 | 0.004 | 0.168 | 5 Hydroxytryptamine 3A antagonist | 0.087 0.025 CID_34180809 | ||
| 0.179 | 0.016 | 0.179 | Protein kinase C mu inhibitor | 0.135 0.033 CID_34180809 | ||
| 0.195 | 0.032 | 0.195 | Toll-Like receptor antagonist | 0.161 0.048 CID_34180809 | ||
| 0.193 | 0.032 | 0.193 | Sodium channel (voltage-gated) blocker | 0.107 0.101 CID_34180809 | ||
| 0.186 | 0.026 | 0.186 | Ferrochelatase inhibitor | 0.129 0.048 CID_34180809 | ||
| 0.178 | 0.019 | 0.178 | Protein kinase C gamma inhibitor | 0.169 0.023 CID_34180809 | ||
| 0.183 | 0.025 | 0.183 | Aurora-C kinase inhibitor | 0.145 0.057 CID_34180809 | ||
| 0.162 | 0.005 | 0.162 | Toll-Like receptor 7 antagonist | 0.087 0.031 CID_34180809 | ||
| 0.191 | 0.036 | 0.191 | Sodium channel blocker | 0.106 0.104 CID_34180809 | ||
| 0.192 | 0.037 | 0.211 | Alpha-N-acetylglucosaminidase inhibitor | 0.211 0.031 CID_34180809 | CID_34180809 | |
| 0.24 | 0.085 | 0.24 | 5 Hydroxytryptamine 1E antagonist | 0.2 0.131 CID_34180809 | ||
| 0.161 | 0.006 | 0.161 | Protein kinase B beta inhibitor | 0.116 0.017 CID_34180809 | ||
| 0.175 | 0.021 | 0.175 | Interleukin 8 antagonist | 0.161 0.028 CID_34180809 | ||
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | 0.154 0.02 CID_34180809 | ||
| 0.198 | 0.048 | 0.198 | Protein kinase C nu inhibitor | 0.155 0.067 CID_34180809 | ||
| 0.17 | 0.021 | 0.179 | GABA C receptor antagonist | 0.179 0.018 CID_34180809 | CID_34180809 | |
| 0.234 | 0.085 | 0.266 | Tyrosine 3 hydroxylase inhibitor | 0.266 0.054 CID_34180809 | CID_34180809 | |
| 0.162 | 0.014 | 0.162 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.161 | 0.015 | 0.161 | CDK2/cyclin E2 inhibitor | 0.108 0.026 CID_34180809 | ||
| 0.15 | 0.004 | 0.15 | Polo-like kinase-2 inhibitor | 0.132 0.005 CID_34180809 | ||
| 0.161 | 0.015 | 0.161 | Pim-3 kinase inhibitor | 0.121 0.031 CID_34180809 | ||
| 0.159 | 0.014 | 0.159 | Inducible nitric-oxide synthase inhibitor | 0.09 0.047 CID_34180809 | ||
| 0.149 | 0.005 | 0.149 | Histamine agonist | 0.066 0.022 CID_34180809 | ||
| 0.162 | 0.018 | 0.162 | Nitric-oxide synthase inhibitor | 0.096 0.066 CID_34180809 | ||
| 0.152 | 0.009 | 0.152 | Glutamate release inhibitor | 0.143 0.012 CID_34180809 | ||
| 0.211 | 0.069 | 0.218 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.218 0.064 CID_34180809 | CID_34180809 | |
| 0.233 | 0.091 | 0.233 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.166 | 0.028 | 0.166 | Antihistaminic | |||
| 0.15 | 0.015 | 0.15 | MAP-kinase-activated kinase inhibitor | 0.099 0.04 CID_34180809 | ||
| 0.139 | 0.005 | 0.139 | Cyclin-dependent kinase 6 inhibitor | 0.102 0.009 CID_34180809 | ||
| 0.151 | 0.017 | 0.151 | Acetylcholine nicotinic agonist | 0.11 0.031 CID_34180809 | ||
| 0.15 | 0.017 | 0.152 | Interleukin 1 beta converting enzyme inhibitor | 0.152 0.016 CID_34180809 | CID_34180809 | |
| 0.16 | 0.027 | 0.16 | Histamine antagonist | |||
| 0.135 | 0.004 | 0.135 | Protein kinase (CK1) epsilon inhibitor | 0.05 0.013 CID_34180809 | ||
| 0.172 | 0.041 | 0.172 | MAP kinase 3 inhibitor | 0.124 0.123 CID_34180809 | ||
| 0.169 | 0.037 | 0.169 | Nav1.3 sodium channel blocker | 0.121 0.073 CID_34180809 | ||
| 0.186 | 0.056 | 0.194 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.194 0.053 CID_34180809 | CID_34180809 | |
| 0.142 | 0.013 | 0.142 | Cyclin-dependent kinase 4 inhibitor | 0.099 0.027 CID_34180809 | ||
| 0.139 | 0.01 | 0.139 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.138 | 0.01 | 0.138 | Nicotinic alpha4beta2 receptor antagonist | 0.121 0.017 CID_34180809 | ||
| 0.137 | 0.012 | 0.137 | CDC7 inhibitor | 0.089 0.03 CID_34180809 | ||
| 0.174 | 0.05 | 0.174 | RET inhibitor | |||
| 0.159 | 0.035 | 0.159 | Beta amyloid protein antagonist | 0.133 0.054 CID_34180809 | ||
| 0.138 | 0.015 | 0.138 | Cyclin A2 inhibitor | 0.066 0.042 CID_34180809 | ||
| 0.146 | 0.024 | 0.146 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.131 0.029 CID_34180809 | ||
| 0.134 | 0.013 | 0.134 | Protein kinase C alpha inhibitor | 0.079 0.035 CID_34180809 | ||
| 0.252 | 0.132 | 0.266 | Vasodilator, coronary | 0.266 0.119 CID_34180809 | CID_34180809 | |
| 0.126 | 0.006 | 0.126 | Protein kinase C beta inhibitor | 0.111 0.009 CID_34180809 | ||
| 0.152 | 0.033 | 0.152 | Cyclin-dependent kinase 9 inhibitor | 0.127 0.042 CID_34180809 | ||
| 0.132 | 0.016 | 0.132 | MAP-kinase-activated kinase 2 inhibitor | 0.082 0.042 CID_34180809 | ||
| 0.131 | 0.015 | 0.131 | Phosphodiesterase V inhibitor | 0.074 0.048 CID_34180809 | ||
| 0.14 | 0.024 | 0.14 | Acetylcholine release stimulant | |||
| 0.206 | 0.091 | 0.212 | RNA-directed DNA polymerase inhibitor | 0.212 0.083 CID_34180809 | CID_34180809 | |
| 0.128 | 0.014 | 0.128 | mTOR complex 2 inhibitor | 0.123 0.016 CID_34180809 | ||
| 0.133 | 0.02 | 0.144 | Adrenaline agonist | 0.144 0.016 CID_34180809 | CID_34180809 | |
| 0.118 | 0.004 | 0.118 | Histamine H4 receptor antagonist | 0.065 0.015 CID_34180809 | ||
| 0.133 | 0.02 | 0.133 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.167 | 0.054 | 0.167 | Ribosomal protein S6 kinase inhibitor | 0.151 0.064 CID_34180809 | ||
| 0.129 | 0.016 | 0.129 | Phosphodiesterase 5A inhibitor | 0.069 0.051 CID_34180809 | ||
| 0.169 | 0.056 | 0.169 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.135 0.074 CID_34180809 | ||
| 0.148 | 0.037 | 0.148 | GABA receptor agonist | 0.091 0.088 CID_34180809 | ||
| 0.141 | 0.03 | 0.141 | Transcription factor STAT6 inhibitor | 0.128 0.046 CID_34180809 | ||
| 0.126 | 0.016 | 0.127 | Protein kinase B alpha inhibitor | 0.127 0.016 CID_34180809 | CID_34180809 | |
| 0.166 | 0.056 | 0.166 | Glycogen synthase kinase-3 alpha inhibitor | 0.127 0.08 CID_34180809 | ||
| 0.116 | 0.007 | 0.116 | 5 Hydroxytryptamine 2 agonist | 0.07 0.019 CID_34180809 | ||
| 0.191 | 0.082 | 0.191 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.183 0.091 CID_34180809 | ||
| 0.113 | 0.006 | 0.113 | Glucosylceramidase inhibitor | 0.099 0.008 CID_34180809 | ||
| 0.114 | 0.007 | 0.114 | Orexin receptor 1 antagonist | 0.071 0.051 CID_34180809 | ||
| 0.13 | 0.023 | 0.13 | Histamine N-methyltransferase inhibitor | 0.097 0.048 CID_34180809 | ||
| 0.146 | 0.04 | 0.146 | Cyclin-dependent kinase 2 inhibitor | 0.088 0.085 CID_34180809 | ||
| 0.136 | 0.03 | 0.136 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.154 | 0.049 | 0.154 | Nav1.6 sodium channel blocker | 0.121 0.094 CID_34180809 | ||
| 0.111 | 0.006 | 0.111 | Toll-Like receptor 8 antagonist | 0.078 0.019 CID_34180809 | ||
| 0.122 | 0.017 | 0.122 | Cyclin A inhibitor | 0.057 0.046 CID_34180809 | ||
| 0.136 | 0.034 | 0.136 | CDK/cyclin complex inhibitor | 0.077 0.072 CID_34180809 | ||
| 0.11 | 0.009 | 0.11 | Orexin receptor antagonist | |||
| 0.112 | 0.011 | 0.112 | 5 Hydroxytryptamine 2A agonist | 0.097 0.016 CID_34180809 | ||
| 0.165 | 0.065 | 0.165 | Cyclin-dependent kinase 8 inhibitor | 0.148 0.081 CID_34180809 | ||
| 0.139 | 0.04 | 0.139 | TRPA1 agonist | 0.135 0.043 CID_34180809 | ||
| 0.14 | 0.042 | 0.143 | DNA repair enzyme inhibitor | 0.143 0.038 CID_34180809 | CID_34180809 | |
| 0.116 | 0.018 | 0.116 | Nav1.7 sodium channel blocker | |||
| 0.115 | 0.019 | 0.115 | CXC chemokine receptor antagonist | |||
| 0.1 | 0.004 | 0.1 | 5 Hydroxytryptamine 2B agonist | 0.062 0.008 CID_34180809 | ||
| 0.107 | 0.013 | 0.107 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.097 | 0.004 | 0.097 | Diamine oxidase inhibitor | 0.075 0.005 CID_34180809 | ||
| 0.15 | 0.058 | 0.15 | Phosphodiesterase inhibitor | |||
| 0.121 | 0.029 | 0.121 | Polo-like kinase-1 inhibitor | 0.101 0.044 CID_34180809 | ||
| 0.105 | 0.013 | 0.105 | CDK4/cyclin D1 inhibitor | 0.082 0.023 CID_34180809 | ||
| 0.123 | 0.032 | 0.123 | Insulin growth factor antagonist | 0.097 0.048 CID_34180809 | ||
| 0.097 | 0.007 | 0.097 | Potassium channel small-conductance Ca-activated blocker | 0.046 0.029 CID_34180809 | ||
| 0.131 | 0.042 | 0.131 | Nav1.5 sodium channel blocker | |||
| 0.15 | 0.061 | 0.153 | MAP kinase kinase 4 inhibitor | 0.153 0.055 CID_34180809 | CID_34180809 | |
| 0.112 | 0.024 | 0.112 | Rho-associated kinase I inhibitor | 0.068 0.059 CID_34180809 | ||
| 0.125 | 0.038 | 0.125 | Interleukin 2 antagonist | |||
| 0.096 | 0.009 | 0.096 | Glutamate (mGluR group I) agonist | 0.047 0.034 CID_34180809 | ||
| 0.141 | 0.055 | 0.141 | Antibacterial (Helicobacter pylori) | |||
| 0.094 | 0.008 | 0.094 | Glutamate (mGluR5) agonist | 0.045 0.033 CID_34180809 | ||
| 0.218 | 0.132 | 0.218 | Insulysin inhibitor | 0.216 0.135 CID_34180809 | ||
| 0.118 | 0.033 | 0.14 | Protein kinase C zeta inhibitor | 0.14 0.023 CID_34180809 | CID_34180809 | |
| 0.116 | 0.031 | 0.116 | Insulin like growth factor 1 antagonist | 0.089 0.051 CID_34180809 | ||
| 0.114 | 0.03 | 0.135 | Porphobilinogen synthase inhibitor | 0.135 0.024 CID_34180809 | CID_34180809 | |
| 0.121 | 0.036 | 0.121 | Acetylcholine agonist | |||
| 0.098 | 0.015 | 0.108 | MAP kinase kinase 7 inhibitor | 0.108 0.008 CID_34180809 | CID_34180809 | |
| 0.092 | 0.01 | 0.092 | Sphingosine kinase 2 inhibitor | 0.092 0.01 CID_34180809 | ||
| 0.106 | 0.024 | 0.106 | Dopamine D4 antagonist | |||
| 0.164 | 0.082 | 0.182 | Phospholipase C inhibitor | 0.182 0.058 CID_34180809 | CID_34180809 | |
| 0.121 | 0.039 | 0.121 | Hedgehog signaling inhibitor | |||
| 0.178 | 0.096 | 0.182 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.182 0.092 CID_34180809 | CID_34180809 | |
| 0.09 | 0.009 | 0.09 | Potassium channel (Inward rectifier) blocker | 0.067 0.019 CID_34180809 | ||
| 0.103 | 0.023 | 0.103 | Neuronal nicotinic receptor antagonist | 0.082 0.035 CID_34180809 | ||
| 0.115 | 0.034 | 0.115 | Histamine H1 receptor antagonist | |||
| 0.11 | 0.03 | 0.11 | GABA A receptor agonist | |||
| 0.098 | 0.018 | 0.098 | Protein kinase C eta inhibitor | 0.092 0.019 CID_34180809 | ||
| 0.085 | 0.006 | 0.085 | Alpha 1L adrenoreceptor antagonist | 0.068 0.014 CID_34180809 | ||
| 0.12 | 0.042 | 0.12 | Pim-1 kinase inhibitor | 0.084 0.074 CID_34180809 | ||
| 0.093 | 0.015 | 0.093 | Nicotinic neuronal receptor agonist | 0.059 0.037 CID_34180809 | ||
| 0.112 | 0.034 | 0.112 | Dopamine antagonist | |||
| 0.092 | 0.014 | 0.092 | mTOR inhibitor | 0.072 0.021 CID_34180809 | ||
| 0.094 | 0.016 | 0.094 | CDK4/cyclin D inhibitor | 0.065 0.032 CID_34180809 | ||
| 0.095 | 0.018 | 0.095 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.064 0.028 CID_34180809 | ||
| 0.166 | 0.089 | 0.166 | CDC-like kinase 4 inhibitor | |||
| 0.087 | 0.011 | 0.105 | Nicotinic receptor alpha4 subunit antagonist | 0.105 0.007 CID_34180809 | CID_34180809 | |
| 0.143 | 0.068 | 0.143 | Cytokine production inhibitor | |||
| 0.097 | 0.022 | 0.097 | Phosphatidylinositol kinase inhibitor | 0.056 0.045 CID_34180809 | ||
| 0.157 | 0.082 | 0.157 | Protein kinase (CK1) gamma 3 inhibitor | 0.146 0.094 CID_34180809 | ||
| 0.086 | 0.012 | 0.086 | Protein kinase C theta inhibitor | 0.062 0.033 CID_34180809 | ||
| 0.087 | 0.013 | 0.087 | Cyclin D1 inhibitor | 0.07 0.028 CID_34180809 | ||
| 0.091 | 0.017 | 0.091 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.078 0.021 CID_34180809 | ||
| 0.082 | 0.008 | 0.082 | Alpha 1b adrenoreceptor agonist | 0.069 0.013 CID_34180809 | ||
| 0.113 | 0.04 | 0.166 | Hepatocyte growth factor antagonist | 0.166 0.018 CID_34180809 | CID_34180809 | |
| 0.099 | 0.026 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 CID_34180809 | CID_34180809 | |
| 0.078 | 0.005 | 0.078 | Alpha 1d adrenoreceptor agonist | 0.058 0.012 CID_34180809 | ||
| 0.12 | 0.048 | 0.12 | Protein kinase (CK2) inhibitor | 0.12 0.048 CID_34180809 | ||
| 0.175 | 0.103 | 0.175 | Anticonvulsant | |||
| 0.075 | 0.004 | 0.075 | Histamine H4 receptor agonist | 0.027 0.008 CID_34180809 | ||
| 0.107 | 0.035 | 0.107 | Acetylcholine nicotinic antagonist | 0.085 0.05 CID_34180809 | ||
| 0.124 | 0.053 | 0.124 | Cyclin-dependent kinase 1 inhibitor | 0.102 0.065 CID_34180809 | ||
| 0.124 | 0.053 | 0.124 | MAP kinase 13 inhibitor | |||
| 0.082 | 0.011 | 0.082 | 5 Hydroxytryptamine 1B agonist | 0.055 0.033 CID_34180809 | ||
| 0.091 | 0.021 | 0.091 | Phospholipase D inhibitor | 0.075 0.043 CID_34180809 | ||
| 0.087 | 0.018 | 0.087 | Dopamine D4 agonist | |||
| 0.088 | 0.019 | 0.088 | Glutamate (mGluR7) antagonist | |||
| 0.09 | 0.022 | 0.09 | Protein kinase C iota inhibitor | |||
| 0.125 | 0.057 | 0.125 | Calcium channel N-type blocker | |||
| 0.081 | 0.013 | 0.081 | Dipeptidyl peptidase inhibitor | |||
| 0.098 | 0.031 | 0.098 | Focal adhesion kinase 1 inhibitor | |||
| 0.121 | 0.054 | 0.121 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.073 CID_34180809 | ||
| 0.091 | 0.024 | 0.091 | Secretase beta inhibitor | 0.075 0.043 CID_34180809 | ||
| 0.105 | 0.04 | 0.105 | Alpha 2d adrenoreceptor antagonist | 0.087 0.08 CID_34180809 | ||
| 0.07 | 0.005 | 0.07 | Alpha 1L adrenoreceptor agonist | 0.055 0.012 CID_34180809 | ||
| 0.076 | 0.011 | 0.076 | Cyclin D3 inhibitor | 0.055 0.019 CID_34180809 | ||
| 0.074 | 0.009 | 0.074 | CC chemokine 4 receptor antagonist | 0.05 0.027 CID_34180809 | ||
| 0.073 | 0.009 | 0.073 | Dipeptidyl peptidase IV inhibitor | 0.041 0.04 CID_34180809 | ||
| 0.147 | 0.082 | 0.177 | CF transmembrane conductance regulator agonist | 0.177 0.039 CID_34180809 | CID_34180809 | |
| 0.083 | 0.019 | 0.083 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.062 0.03 CID_34180809 | ||
| 0.104 | 0.04 | 0.104 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.154 | 0.091 | 0.16 | Neurotensin receptor agonist | 0.16 0.079 CID_34180809 | CID_34180809 | |
| 0.082 | 0.019 | 0.088 | Heat shock protein 90 beta antagonist | 0.088 0.016 CID_34180809 | CID_34180809 | |
| 0.096 | 0.034 | 0.096 | Dopamine D2 antagonist | |||
| 0.111 | 0.049 | 0.111 | CDK2/cyclin A inhibitor | |||
| 0.081 | 0.019 | 0.081 | Protein kinase C epsilon inhibitor | |||
| 0.085 | 0.024 | 0.085 | Carbonic anhydrase stimulant | 0.069 0.032 CID_34180809 | ||
| 0.117 | 0.056 | 0.117 | Aurora-A kinase inhibitor | |||
| 0.097 | 0.037 | 0.097 | CYP2A6 inhibitor | |||
| 0.139 | 0.079 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.058 CID_34180809 | CID_34180809 | |
| 0.068 | 0.008 | 0.068 | Orexin receptor 2 antagonist | |||
| 0.093 | 0.034 | 0.093 | Acetylcholine M4 receptor antagonist | |||
| 0.068 | 0.009 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.064 0.011 CID_34180809 | ||
| 0.086 | 0.028 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.075 | 0.017 | 0.075 | Cyclin A1 inhibitor | 0.057 0.044 CID_34180809 | ||
| 0.124 | 0.066 | 0.124 | MAP kinase 12 inhibitor | |||
| 0.133 | 0.075 | 0.133 | Tyrosine-protein kinase receptor antagonist | |||
| 0.066 | 0.009 | 0.066 | Geranyltranstransferase inhibitor | 0.053 0.02 CID_34180809 | ||
| 0.096 | 0.039 | 0.096 | Histamine H2 receptor antagonist | |||
| 0.076 | 0.019 | 0.08 | Sphingosine kinase inhibitor | 0.08 0.016 CID_34180809 | CID_34180809 | |
| 0.149 | 0.093 | 0.149 | CDC-like kinase 2 inhibitor | |||
| 0.138 | 0.082 | 0.138 | Thiol protease inhibitor | |||
| 0.063 | 0.007 | 0.063 | Histamine H1 receptor agonist | 0.041 0.038 CID_34180809 | ||
| 0.064 | 0.01 | 0.064 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.107 | 0.053 | 0.132 | UDP-glucose 4-epimerase inhibitor | 0.132 0.036 CID_34180809 | CID_34180809 | |
| 0.069 | 0.015 | 0.069 | Dopamine D5 antagonist | 0.046 0.028 CID_34180809 | ||
| 0.058 | 0.005 | 0.058 | Protein kinase (CK2) beta inhibitor | 0.053 0.006 CID_34180809 | ||
| 0.062 | 0.008 | 0.062 | Nerve growth factor antagonist | 0.054 0.014 CID_34180809 | ||
| 0.129 | 0.076 | 0.129 | Interleukin 1 antagonist | |||
| 0.098 | 0.046 | 0.112 | NADH dehydrogenase inhibitor | 0.112 0.033 CID_34180809 | CID_34180809 | |
| 0.086 | 0.033 | 0.086 | Phosphodiesterase VI inhibitor | |||
| 0.104 | 0.052 | 0.104 | MAP kinase kinase 1 inhibitor | |||
| 0.09 | 0.038 | 0.09 | Transforming growth factor beta 3 antagonist | |||
| 0.055 | 0.004 | 0.055 | Nicotinic alpha4 receptor agonist | 0.03 0.004 CID_34180809 | ||
| 0.071 | 0.021 | 0.071 | Nicotinic receptor alpha7 subunit antagonist | 0.056 0.034 CID_34180809 | ||
| 0.073 | 0.023 | 0.073 | Pim-2 kinase inhibitor | 0.055 0.038 CID_34180809 | ||
| 0.089 | 0.04 | 0.089 | Rho-associated kinase inhibitor | |||
| 0.143 | 0.094 | 0.167 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.167 0.079 CID_34180809 | CID_34180809 | |
| 0.073 | 0.025 | 0.073 | Cyclin H inhibitor | 0.054 0.047 CID_34180809 | ||
| 0.071 | 0.022 | 0.071 | Ca(v)3.2 blocker | 0.055 0.05 CID_34180809 | ||
| 0.068 | 0.019 | 0.068 | Lysine-specific demethylase 1A inhibitor | 0.058 0.031 CID_34180809 | ||
| 0.081 | 0.032 | 0.081 | Potassium channel (Tandem pore domain) blocker | |||
| 0.081 | 0.032 | 0.081 | Cyclin E inhibitor | |||
| 0.147 | 0.098 | 0.147 | Antipruritic | |||
| 0.077 | 0.029 | 0.077 | DNA gyrase inhibitor | 0.061 0.047 CID_34180809 | ||
| 0.12 | 0.072 | 0.12 | TRKB antagonist | |||
| 0.135 | 0.087 | 0.135 | Cytidine deaminase inhibitor | |||
| 0.052 | 0.005 | 0.052 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 CID_34180809 | ||
| 0.088 | 0.042 | 0.088 | Vanilloid antagonist | |||
| 0.05 | 0.004 | 0.05 | Nicotinic alpha4beta2 receptor agonist | 0.042 0.007 CID_34180809 | ||
| 0.06 | 0.014 | 0.06 | Histamine H2 receptor agonist | |||
| 0.112 | 0.067 | 0.112 | Protein kinase (CK2) alpha inhibitor | 0.104 0.073 CID_34180809 | ||
| 0.055 | 0.01 | 0.055 | Potassium channel small-conductance Ca-activated activator | |||
| 0.061 | 0.016 | 0.061 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.071 | 0.027 | 0.071 | Histone deacetylase SIRT3 inhibitor | 0.063 0.04 CID_34180809 | ||
| 0.113 | 0.07 | 0.113 | Aurora-B kinase inhibitor | |||
| 0.138 | 0.095 | 0.138 | Interferon gamma antagonist | 0.138 0.096 CID_34180809 | ||
| 0.115 | 0.072 | 0.115 | TRKA antagonist | |||
| 0.103 | 0.062 | 0.111 | Adenylate kinase inhibitor | 0.111 0.052 CID_34180809 | CID_34180809 | |
| 0.08 | 0.039 | 0.08 | CDK1/cyclin B1 inhibitor | 0.075 0.042 CID_34180809 | ||
| 0.077 | 0.036 | 0.077 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.087 | 0.047 | 0.087 | Glutamate receptor agonist | |||
| 0.074 | 0.035 | 0.074 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.052 | 0.012 | 0.052 | DNA gyrase subunit B inhibitor | 0.035 0.032 CID_34180809 | ||
| 0.084 | 0.045 | 0.084 | Fibroblast growth factor 3 antagonist | |||
| 0.09 | 0.053 | 0.09 | Phosphodiesterase IV inhibitor | |||
| 0.097 | 0.06 | 0.097 | Fibroblast growth factor 1 antagonist | |||
| 0.067 | 0.029 | 0.067 | Cyclin E1 inhibitor | |||
| 0.19 | 0.153 | 0.19 | MAP kinase kinase 3 inhibitor | |||
| 0.164 | 0.127 | 0.258 | Aldehyde oxidase inhibitor | 0.258 0.079 CID_34180809 | CID_34180809 | |
| 0.072 | 0.037 | 0.072 | Dopamine D3 antagonist | |||
| 0.051 | 0.016 | 0.053 | Sphingosine kinase 1 inhibitor | 0.053 0.013 CID_34180809 | CID_34180809 | |
| 0.059 | 0.024 | 0.059 | Purinergic P2X antagonist | |||
| 0.089 | 0.054 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.066 CID_34180809 | ||
| 0.096 | 0.062 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.047 | 0.013 | 0.047 | Glucose-dependent insulinotropic receptor agonist | 0.04 0.017 CID_34180809 | ||
| 0.054 | 0.02 | 0.054 | Stearoyl-CoA desaturase inhibitor | |||
| 0.114 | 0.08 | 0.114 | MAP kinase kinase inhibitor | |||
| 0.042 | 0.009 | 0.042 | Dopamine autoreceptor agonist | |||
| 0.056 | 0.023 | 0.056 | Histamine H3 receptor antagonist | |||
| 0.043 | 0.01 | 0.043 | CDK6/cyclin D3 inhibitor | 0.034 0.023 CID_34180809 | ||
| 0.043 | 0.01 | 0.043 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.066 | 0.034 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.042 | 0.01 | 0.042 | Vanilloid 4 antagonist | 0.033 0.022 CID_34180809 | ||
| 0.036 | 0.005 | 0.036 | Imidazoline I1 receptor antagonist | |||
| 0.072 | 0.042 | 0.072 | Acetylcholine M5 receptor agonist | |||
| 0.061 | 0.031 | 0.061 | Nicotinic alpha7 receptor agonist | |||
| 0.129 | 0.1 | 0.129 | Src kinase inhibitor | |||
| 0.063 | 0.033 | 0.08 | Alcohol oxidase inhibitor | 0.08 0.024 CID_34180809 | CID_34180809 | |
| 0.059 | 0.03 | 0.059 | Epithelial sodium channel blocker | 0.052 0.043 CID_34180809 | ||
| 0.034 | 0.005 | 0.034 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.072 | 0.044 | 0.072 | Cyclin B3 inhibitor | 0.067 0.048 CID_34180809 | ||
| 0.125 | 0.097 | 0.125 | Death-associated protein kinase 1 inhibitor | |||
| 0.073 | 0.045 | 0.073 | Amidase inhibitor | 0.067 0.053 CID_34180809 | ||
| 0.202 | 0.175 | 0.208 | Antithrombotic | 0.208 0.168 CID_34180809 | CID_34180809 | |
| 0.035 | 0.008 | 0.035 | Alpha 1a adrenoreceptor agonist | |||
| 0.046 | 0.019 | 0.046 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.065 | 0.038 | 0.08 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.028 CID_34180809 | CID_34180809 | |
| 0.036 | 0.01 | 0.036 | 5 Hydroxytryptamine 6 agonist | |||
| 0.142 | 0.116 | 0.142 | ATPase inhibitor | |||
| 0.049 | 0.022 | 0.049 | Guanylate cyclase inhibitor | 0.044 0.027 CID_34180809 | ||
| 0.046 | 0.021 | 0.067 | Dopamine D5 agonist | 0.067 0.009 CID_34180809 | CID_34180809 | |
| 0.046 | 0.02 | 0.047 | G protein-coupled receptor agonist | 0.047 0.019 CID_34180809 | CID_34180809 | |
| 0.037 | 0.012 | 0.037 | CDK4/cyclin D3 inhibitor | 0.031 0.016 CID_34180809 | ||
| 0.062 | 0.037 | 0.062 | Potassium channel (Ca-activated) blocker | |||
| 0.104 | 0.079 | 0.104 | CDK3/cyclin E inhibitor | 0.098 0.091 CID_34180809 | ||
| 0.096 | 0.071 | 0.096 | mTOR complex 1 inhibitor | |||
| 0.066 | 0.042 | 0.066 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.078 | 0.054 | 0.078 | Viral attachment inhibitor | 0.073 0.066 CID_34180809 | ||
| 0.061 | 0.038 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.143 | 0.12 | 0.143 | Clk dual-specificity kinase inhibitor | |||
| 0.028 | 0.005 | 0.028 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 CID_34180809 | ||
| 0.08 | 0.057 | 0.081 | Glycine receptor antagonist | 0.081 0.056 CID_34180809 | CID_34180809 | |
| 0.057 | 0.034 | 0.057 | Myc inhibitor | |||
| 0.037 | 0.015 | 0.037 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.035 | 0.013 | 0.035 | DNA topoisomerase IV inhibitor | |||
| 0.086 | 0.065 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.067 | 0.046 | 0.067 | Dopamine agonist | 0.065 0.048 CID_34180809 | ||
| 0.025 | 0.005 | 0.025 | Complement factor D inhibitor | |||
| 0.127 | 0.106 | 0.127 | Neuropeptide Y1 antagonist | |||
| 0.068 | 0.048 | 0.068 | Exportin-1 inhibitor | |||
| 0.094 | 0.073 | 0.094 | Gastric antisecretory | |||
| 0.07 | 0.049 | 0.07 | Syk tyrosine kinase inhibitor | 0.062 0.057 CID_34180809 | ||
| 0.06 | 0.04 | 0.06 | Biliverdin reductase inhibitor | 0.052 0.05 CID_34180809 | ||
| 0.077 | 0.057 | 0.077 | MAP kinase 7 inhibitor | |||
| 0.036 | 0.017 | 0.036 | ATR kinase inhibitor | |||
| 0.023 | 0.003 | 0.023 | Cyclin D2 inhibitor | 0.016 0.005 CID_34180809 | ||
| 0.048 | 0.028 | 0.048 | Purinergic P2X4 antagonist | 0.044 0.036 CID_34180809 | ||
| 0.09 | 0.071 | 0.16 | Creatine kinase inhibitor | 0.16 0.02 CID_34180809 | CID_34180809 | |
| 0.024 | 0.006 | 0.024 | Alpha 2b adrenoreceptor agonist | |||
| 0.061 | 0.043 | 0.061 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.035 | 0.017 | 0.035 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Myristoyl transferase inhibitor | |||
| 0.11 | 0.093 | 0.11 | Lck kinase inhibitor | |||
| 0.037 | 0.02 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.047 | 0.029 | 0.047 | CDK7/cyclin H inhibitor | |||
| 0.022 | 0.006 | 0.022 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.015 CID_34180809 | ||
| 0.1 | 0.084 | 0.1 | Protein kinase (CK1) gamma 2 inhibitor | 0.096 0.089 CID_34180809 | ||
| 0.032 | 0.016 | 0.032 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.023 | 0.008 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.046 | 0.03 | 0.054 | Mannosidase inhibitor | 0.054 0.022 CID_34180809 | CID_34180809 | |
| 0.033 | 0.017 | 0.033 | 5 Hydroxytryptamine 1D agonist | |||
| 0.078 | 0.062 | 0.078 | Protein kinase A inhibitor | 0.077 0.063 CID_34180809 | ||
| 0.034 | 0.02 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.018 CID_34180809 | CID_34180809 | |
| 0.11 | 0.096 | 0.11 | Nav1.2 sodium channel blocker | |||
| 0.089 | 0.075 | 0.102 | Interleukin 12 antagonist | 0.102 0.051 CID_34180809 | CID_34180809 | |
| 0.068 | 0.054 | 0.068 | Telomerase inhibitor | |||
| 0.113 | 0.099 | 0.113 | Growth factor antagonist | 0.11 0.103 CID_34180809 | ||
| 0.072 | 0.058 | 0.072 | Vanilloid 4 agonist | |||
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.056 | 0.043 | 0.056 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.137 | 0.125 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.077 | 0.065 | 0.077 | AXL receptor tyrosine kinase inhibitor | |||
| 0.058 | 0.046 | 0.065 | Adenosine A2a receptor antagonist | 0.065 0.04 CID_34180809 | CID_34180809 | |
| 0.061 | 0.05 | 0.061 | Fibroblast growth factor 2 antagonist | |||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 CID_34180809 | ||
| 0.059 | 0.048 | 0.059 | CDK1/cyclin B inhibitor | |||
| 0.05 | 0.039 | 0.05 | Aconitate hydratase inhibitor | |||
| 0.018 | 0.007 | 0.018 | CXC chemokine 4 receptor agonist | |||
| 0.059 | 0.048 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.026 | 0.016 | 0.026 | Acid ceramidase inhibitor | |||
| 0.079 | 0.069 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Glutamate (mGluR1a) antagonist | |||
| 0.057 | 0.047 | 0.059 | Ryanodine receptor antagonist | 0.059 0.041 CID_34180809 | CID_34180809 | |
| 0.029 | 0.019 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 CID_34180809 | ||
| 0.054 | 0.044 | 0.054 | Glutamate (mGluR1) antagonist | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.051 | 0.042 | 0.051 | Acetylcholine muscarinic agonist | |||
| 0.029 | 0.02 | 0.029 | Cyclin E2 inhibitor | |||
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.067 | 0.058 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.014 | 0.006 | 0.014 | Egl nine homolog 3 inhibitor | |||
| 0.031 | 0.023 | 0.052 | Cholesterol ester transfer protein antagonist | 0.052 0.006 CID_34180809 | CID_34180809 | |
| 0.022 | 0.014 | 0.022 | Alpha 2d adrenoreceptor agonist | |||
| 0.03 | 0.022 | 0.03 | Acetylcholine M4 receptor agonist | |||
| 0.092 | 0.085 | 0.107 | Beta glucuronidase inhibitor | 0.107 0.06 CID_34180809 | CID_34180809 | |
| 0.028 | 0.021 | 0.034 | Estrogen-related receptor gamma antagonist | 0.034 0.01 CID_34180809 | CID_34180809 | |
| 0.013 | 0.006 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.058 | 0.051 | 0.058 | Adenosine A2 receptor antagonist | 0.058 0.051 CID_34180809 | ||
| 0.083 | 0.076 | 0.098 | Prolactin inhibitor | 0.098 0.057 CID_34180809 | CID_34180809 | |
| 0.117 | 0.111 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.013 | 0.007 | 0.013 | Melatonin 5 antagonist | |||
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.031 | 0.026 | 0.031 | Protein kinase C beta II inhibitor | |||
| 0.06 | 0.056 | 0.06 | Phosphodiesterase 4B inhibitor | |||
| 0.049 | 0.045 | 0.057 | Alpha-mannosidase inhibitor | 0.057 0.032 CID_34180809 | CID_34180809 | |
| 0.041 | 0.037 | 0.041 | Oleamide hydrolase inhibitor | |||
| 0.074 | 0.07 | 0.074 | I kappa B kinase inhibitor | |||
| 0.058 | 0.054 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.053 | 0.05 | 0.053 | CDK2/cyclin E inhibitor | |||
| 0.016 | 0.012 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.056 | 0.052 | 0.056 | Purinergic P2 antagonist | |||
| 0.08 | 0.077 | 0.08 | Bromodomain-containing protein 2 inhibitor | |||
| 0.044 | 0.041 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.078 | 0.074 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.068 CID_34180809 | CID_34180809 | |
| 0.103 | 0.1 | 0.103 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.061 | 0.057 | 0.061 | Check point kinase 1 inhibitor | |||
| 0.02 | 0.017 | 0.02 | Factor XIII inhibitor | |||
| 0.062 | 0.059 | 0.102 | Histidine decarboxylase inhibitor | 0.102 0.031 CID_34180809 | CID_34180809 | |
| 0.044 | 0.041 | 0.044 | Transforming growth factor beta 1 antagonist | |||
| 0.05 | 0.047 | 0.066 | Beta 1 adrenoreceptor antagonist | 0.066 0.03 CID_34180809 | CID_34180809 | |
| 0.088 | 0.086 | 0.088 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.017 | 0.014 | 0.017 | Cyclin T1 inhibitor | |||
| 0.066 | 0.064 | 0.066 | Protein kinase B gamma inhibitor | |||
| 0.026 | 0.023 | 0.026 | LFA antagonist | |||
| 0.049 | 0.048 | 0.059 | Argininosuccinate synthase inhibitor | 0.059 0.038 CID_34180809 | CID_34180809 | |
| 0.045 | 0.045 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.029 CID_34180809 | CID_34180809 | |
| 0.013 | 0.013 | 0.015 | Egl nine homolog 1 inhibitor | 0.015 0.01 CID_34180809 | CID_34180809 | |
| 0.058 | 0.06 | 0.067 | Interferon inducer | 0.067 0.039 CID_34180809 | CID_34180809 | |
| 0.043 | 0.046 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.039 CID_34180809 | CID_34180809 | |
| 0.043 | 0.048 | 0.046 | Topoisomerase II beta inhibitor | 0.046 0.04 CID_34180809 | CID_34180809 | |
| 0.028 | 0.035 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.029 CID_34180809 | CID_34180809 | |
| 0.105 | 0.112 | 0.157 | Protein kinase stimulant | 0.157 0.064 CID_34180809 | CID_34180809 | |
| 0.062 | 0.069 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.051 CID_34180809 | CID_34180809 | |
| 0.135 | 0.143 | 0.158 | Succinate dehydrogenase inhibitor | 0.158 0.098 CID_34180809 | CID_34180809 | |
| 0.142 | 0.151 | 0.187 | Neurotrophic factor enhancer | 0.187 0.09 CID_34180809 | CID_34180809 | |
| 0.076 | 0.085 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | 0.087 0.068 CID_34180809 | CID_34180809 | |
| 0.068 | 0.078 | 0.077 | GABA B receptor agonist | 0.077 0.049 CID_34180809 | CID_34180809 | |
| 0.028 | 0.044 | 0.036 | Dopamine D3 agonist | 0.036 0.032 CID_34180809 | CID_34180809 | |
| 0.057 | 0.074 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 CID_34180809 | CID_34180809 | |
| 0.065 | 0.082 | 0.078 | Interferon agonist | 0.078 0.055 CID_34180809 | CID_34180809 | |
| 0.049 | 0.07 | 0.071 | Phosphofructokinase-1 inhibitor | 0.071 0.047 CID_34180809 | CID_34180809 | |
| 0.144 | 0.165 | 0.163 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.163 0.12 CID_34180809 | CID_34180809 | |
| 0.05 | 0.076 | 0.063 | Beta adrenoreceptor antagonist | 0.063 0.049 CID_34180809 | CID_34180809 | |
| 0.168 | 0.198 | 0.182 | Cholesterol antagonist | 0.182 0.181 CID_34180809 | CID_34180809 | |
| 0.112 | 0.148 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 CID_34180809 | CID_34180809 | |
| 0.082 | 0.121 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.066 CID_34180809 | CID_34180809 | |
| 0.061 | 0.101 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.059 CID_34180809 | CID_34180809 | |
| 0.05 | 0.091 | 0.065 | Glutamate decarboxylase inhibitor | 0.065 0.061 CID_34180809 | CID_34180809 | |
| 0.096 | 0.148 | 0.113 | Cell wall synthesis inhibitor | 0.113 0.11 CID_34180809 | CID_34180809 | |
| 0.066 | 0.129 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.073 CID_34180809 | CID_34180809 | |
| 0.021 | 0.089 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 CID_34180809 | CID_34180809 | |
| 0.096 | 0.168 | 0.117 | Insulin secretagoues | 0.117 0.115 CID_34180809 | CID_34180809 | |
| 0.076 | 0.161 | 0.123 | Toll-Like receptor 2 antagonist | 0.123 0.075 CID_34180809 | CID_34180809 | |
| 0.16 | 0.26 | 0.314 | Toll-Like receptor 7 agonist | 0.314 0.102 CID_34180809 | CID_34180809 | |
| 0.158 | 0.263 | 0.31 | Toll-Like receptor agonist | 0.31 0.104 CID_34180809 | CID_34180809 | |
| 0.048 | 0.195 | 0.678 | Chelator | 0.678 0.003 CID_34180809 | CID_34180809 | |
| 0.017 | 0.254 | 0.138 | Purinergic P2X2 antagonist | 0.138 0.014 CID_34180809 | CID_34180809 | |
| 0.037 | 0.319 | 0.116 | Lipid peroxidase inhibitor | 0.116 0.098 CID_34180809 | CID_34180809 | |
| 0.021 | 0.458 | 0.143 | Estrogen receptor beta antagonist | 0.143 0.017 CID_34180809 | CID_34180809 | |
| 0.005 | 0.499 | 0.056 | Nicotinic acid receptor 2 agonist | 0.056 0.012 CID_34180809 | CID_34180809 | |
| 0.023 | 0.544 | 0.14 | Estrogen antagonist | 0.14 0.028 CID_34180809 | CID_34180809 | |
| 0.012 | 0.714 | 0.357 | Antioxidant | 0.357 0.045 CID_34180809 | CID_34180809 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |